AI주식인사이트AI Stock Insight
B

녹십자엠에스

142280KOSDAQ

60.0 / 100

Reference Date: 2026-10-23

Financial Score22.5 / 40
News Sentiment12.5 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Surged 17.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Lotte MSD primarily operates in diagnostic reagents (54.1%), blood glucose management (14.4%), and hemodialysis solutions (31.1%), focusing on the development and sales of medical devices and diagnostic products. The company is advancing the development of multi-diagnostic platforms using AI and genomic analysis in the diagnostic reagents sector, while expanding its hemodialysis solution market through collaborations with global firms.

Number of Employees

131people

Average Salary

47.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
21.42Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
1.87Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE
7.71Industry Average 8.002.5Point

Below industry avg

Debt Ratio
18.88Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.4% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲26.7% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 3,620Won52-week high 6,23052-week low 2,395
1-month return6.0Point

1m +17.15% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0